Longevity Startup to Conduct Human Trials for Anti-Aging Gene Therapy
Life Biosciences, a Boston-based biotech company founded by Harvard professor David Sinclair, is testing a cellular reprogramming treatment to target aging.
The treatment aims to rejuvenate cells without altering their core function, potentially addressing age-related diseases such as Alzheimer's, Type 2 diabetes, and Parkinson's.
This potential breakthrough for longevity science also raises a host of ethical concerns, from overpopulation to “hyper-beautification.”
The company is set to become the first to conduct human clinical trials for this type of therapy.
Author's summary: Life Biosciences tests anti-aging gene therapy.
More News
- Choose New Jersey President and CEO Mathews to Join PSEG
- Stephen A. Smith Questions Why Chris Grier Got Fired Before Mike McDaniel After Dolphins' Embarrassing Loss
- Madden 26 Player Ratings For Week 9 - Biggest Winners & Losers
- Philadelphia Eagles QB Jalen Hurts Dressed As God For Halloween
- Wemby’s Evolution Is Scary: Spurs Phenom Dominates Again, Leaves Heat Defenders Helpless
- Bam Adebayo's evolution into 'three-level scorer' starts with Heat's new offense
- Loss to Bucks stunk, but Warriors' Jimmy Butler knows key to returning to 'flowers and daisies'
- Florence + The Machine Return With Everybody Scream And Irish Concert Dates! | SPIN1038
- Patriots' Rhamondre Stevenson is out for Sunday's game vs Falcons
- HSE Nursing Service unavailable on Tory Island this weekend - Donegal News